SUMMARY The lipoxygenase products of arachidonic acid (AA) metabolism, 5-hydroxyeicosatetraenoic acid (5-HETE) and leucotriene B4 (LTB4), are considered to have an important pathophysiological role in inflammatory bowel disease by stimulating the inflammatory response and by contributing to the diarrhoea. The present studies were designed to investigate the effect of the physiological stimulants bradykinin (BK) and 5-hydroxytryptamine (5-HT), in addition to the influence of the calcium ionophore A23187, on the source of AA release and 5-lipoxygenation in human neutrophils (PMNs) in vitro. This was done to elucidate the specificity of the mechanism by which PMNs respond to physiological, extracellular Ca2' dependent agonists. The results of the study indicate that stimulation of 1-'4C-AA-prelabelled PMNs with BK liberates AA mainly from phosphatidylinositol, while A23187 causes release of AA from phosphatidylcholine, phosphatidylethanolamine, and possibly phosphatidylserine. Furthermore BK (10-9-10-6M) dose-dependently stimulated the formation of 5-HETE and LTB4, reaching a maximum at 10-7M, while 5-HT (10-8-10-4M) released only negligible amounts of eicosanoids, similar to those observed in control experiments. Stimulation with A23187 (10-M) caused a high release of both 5-HETE and LTB4. These results offer evidence that BK, but not 5-HT, initiates formation of lipoxygenase products by binding to specific receptors on the external surface of PMNs, whereas A23187 accelerates 5-lipoxygenation through mechanisms which do not involve a cell surface receptor.
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In the diseased colon eicosanoids may potentially contribute to inflammation, in addition to alterations in fluid and electrolyte transport, intestinal motor activity, and mucosal blood flow.' Thus previous studies have observed increased local formation of cyclooxygenase -and lipoxygenase products of arachidonic acid (AA) metabolism in experimental models of colonic inflammation'3 and in man with ulcerative colitis (UC). `7 Although neutrophils (PMNs), which are abundant in the inflamed colonic mucosa,' are considered to metabolise AA via the cyclooxygenase pathway, their major AA metabolites are the lipoxygenase products, 5-hydroxyeicosatetraenoic acid (5-HETE) and leucotriene B4.' "' The latter substance is a potent chemotactic agent that pro-motes migration and stimulates aggregation and degranulation of neutrophils, in addition to release of lysosomal enzymes and superoxide production." 12 Arachidonic acid is liberated not only by phospholipase A2, however, but also by phospholipase C."11 Thus the stimulation of AA metabolism by physical (mechanical, irradiation) or chemical (hypoxia, 'free radicals') damage, which does not require a specific receptor, is associated with an increased turnover of phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphatidylinositol (PI) and catalysed by phospholipase A2.9 ' " On the other hand, the mucosal infiltrate per se may also promote eicosanoid formation and diarrhoea by releasing agents, such as bradykinin (BK) and 5- Time course experiments were carried out to determine the lag until optimum stimulation. Isolation of extracellular radiolabelled metabolites was carried out by centrifugation (8x 103 G, 1 mm) of the cells through dibutyl-phthalate:dinonyl-phthalate; 3:1 (density 1-033 g/ml), and extraction according to Folch.' The radioactive metabolites, 5-HETE and LTB4, were separated by thin layer chromatography and quantified by autoradiography and laser densitometry as previously described. 9 To define the phospholipid groups, from which AA was mobilised, thin layer chromatography analysis of lipid extracts from total cell suspensions was carried out as previously described in detail.9 Shortly, the suspensions were extracted ad modum Folch' and the organic phases evaporated in a stream of nitrogen. The residues were applied to thin-layer chromatography (TLC) using CH2Cl2:methanol: 2-propanol:0-25%KCl:ethylacetate (30:9:25:6:18) as a developing solvent. After autoradiography of the TLC-plates, which were exposed for one week, quantification of the radioactive spots were performed by laser densitometry. Identification of the different phospholipids was performed by cochromatography with pure standards.9
The specific activity of released LTB4 was determined by high pressure 
Results
In a preliminary series of experiments stimulation with BK for 10 minutes was found to cause optimum conditions (Fig. 1) . For (Fig. 2) (p<0.03) , whereas no detectable alterations in PC, PE, or phosphatidylserine (PS) were found (Fig. 2) . By contrast, A23187 caused a relative decrease in radioactivity within PC, PE, and PI by 32% (18-50%; p<001), 27% (12-45%; p<002), and 11% (0-28%; p<0-05), respectively, indicating that AA was released from these three phospholipid pools. Because only small amounts of PS were detected it cannot be excluded that this pool may be responsible for AA release as well.
In non-stimulated PMNs there was no detectable amount of LTB4, but trace amounts of 5-HETE was observed.
Bradykinin (10-9-1006 M) caused a dose dependent increase in the release of both lipoxygenase products, which reached a maximum at 10`M (Fig.  3) . The release corresponded to 2-8% (2.2-6.6%) and 2.3% (0.7-4.9%) of the total radioactivity released as far as 5-HETE and LTB4 are concerned, whereas A23187 resulted in formation of 5-HETE and LTB4 corresponding to 14-9% (9-5-19%) and 5.3% (2-0-7.6%), respectively, of the total radioactivity released.
5-HT (10-8 10-4 M) caused no detectable release of lipoxygenase products (Fig. 1) .
The difference in specific activity of 14C-metabolites, as assessed by high-pressure liquid chromatography for evaluation of the homogeneity of radiolabelling, was negligible wiz 5*4x 108 Bq/ mmol (541-6.9x 108 Bq/mmol) and 6*3x 108 Bq/mmol (4.8-7.4x108 Bq/mmol) for BK and A23187, respectively.
Discussion
These results show that concentrations of BK, comparable with those measured in plasma (10v-10`M), stimulates 5-lipoxygenation of AA in human PMNs, in addition to increasing the release of AA from PI. By contrast, the calcium dependent neurotransmitter, 5-HT, has no effect on AA release and 5-lipoxygenation in the concentration range used. The amount of LTB4 produced by 5 x 106 PMNs, in response to optimal challenge with BK, resulted in a median concentration -that is, 11. 1 nM, within the range which stimulates chemotaxis,'2 whereas the less potent chemoattractant, 5-HETE, did not reach concentrations range sufficiently high to stimulate chemotaxis. 12 The mechanism by which BK stimulates the release and metabolism of AA in human PMNs has not yet been defined, but is probably dependent of stimulation of specific receptors on the external surface of the cells.242526 5-HT which has been reported earlier to increase PI turn-over in other cell types,2' had no effect on AA release and metabolism in human PMNs, which may be caused by lack of specific receptors.
On the other hand, the calcium ionophore, A23187, caused a high release of radio-labelled AA originating in both PI, PC, PE, and probably also PS. At maximum stimulation with A23187 (10 We would tentatively conclude, therefore, that the results of the present study offer evidence for the view that BK, but not 5-HT, adds to the formation of lipoxygenase products, such as LTB4, by binding to specific receptors on the external surface of PMNs, thus promoting inflammation as well as diarrhoea in inflammatory bowel disease. 
